Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Eton Pharmaceuticals, Inc. (ETON) Profit Margins

Over the twelve months to 2026-06-30, Eton Pharmaceuticals, Inc. (ETON) had gross margin 57.9%, operating margin 15.4%, net margin 12.0%, free cash flow margin 14.0%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ETONEton Pharmaceuticals, Inc.Follow ETON — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
1.4B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin52.8%-1017.9%87.1%67.4%66.6%60.0%53.5%57.9%
Operating margin-1939.6%-69515.4%-6.8%-38.9%-3.8%-6.7%-1.1%15.4%
Net margin-1910.3%-71717.9%-9.0%-42.4%-3.0%-9.8%-5.8%12.0%
FCF margin-1994.0%-57425.6%-21.7%22.5%21.5%2.4%12.7%14.0%

USD millions · SEC XBRL

Eton Pharmaceuticals, Inc. — questions

What is Eton Pharmaceuticals, Inc.'s gross margin?
57.9% over the twelve months to 2026-06-30.
What is Eton Pharmaceuticals, Inc.'s operating margin?
15.4% over the twelve months to 2026-06-30.
What is Eton Pharmaceuticals, Inc.'s net profit margin?
12.0% over the twelve months to 2026-06-30.

Every figure on this page comes from Eton Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.